Corporate venture capital (CVC)
This is venture capital funding provided by major corporations to startup companies with a high potential for growth.
Funding is typically sourced through the capital budget of the corporation, as compared to that sourced from investors in the case of the independent venture capital fund. These corporate venture capital arms either invest in ventures that have some level of strategic synergies with their company’s business or they invest because of financial objectives.
The latter may make sense for privately held companies, but many would argue that financial returns should not be the objective of the publicly traded company. This is because, in theory, the public company investors’ interest is in the firm’s core business, and not necessarily in riskier venture investing. Should they be, they would likely be better served to invest directly through a venture capital fund or other private equity vehicles which is focused on such investments.
CVC bring administrative support, infrastructure, management and marketing expertise, and technology to the venture.
Like angel groups and venture capital funds, corporate venture capital arms invest in startups in all stages of development, from seed to the expansion, growth and mezzanine levels. Generally, their desired liquidation event is not an IPO. As indicated above, they tend more toward the acquisition of the startup.
FundingSage’s Listing of CVC Funds
Several of these CVC Funds are spotlighted on our FundingSage Startup Investor Spotlight. Learn more about potential CVC investors there!
301 Inc. (General Mills Venture Arm)
Abbvie Biotech Ventures
Airbus Ventures
Alexandria Venture Investments
Amgen Ventures
Ascension Health Ventures
Astellas Venture Management
AXA Strategic Ventures
Baidu Capital
BASF Venture Capital America, Inc.
Bertelsmann Digital Media Investments
BlueCross BlueShield Venture Partners
BMW i Ventures
Boehringer Ingelheim Ventures
capitalG
Chevron Technology Ventures
CISCO
Comcast Ventures
ConocoPhillips Technology Ventures
Danone Ventures
Dow Ventures
DSM Venturing B.V.
eighteen94 Capital (Kellogg’s VC Fund)
Fosun RZ Capital
GE Ventures
GM Ventures
GV (Google Ventures)
IBM Venture Capital
InMotion Ventures (England)
Intel Capital
Johnson & Johnson Development Corp
Juniper Networks Ventures
Kaiser Permanente Ventures
Kearny Venture Partners
Legend Capital
Lenovo Capital & Incubator Group
Lilly Ventures
Media Tek Ventures
Medtronic Venture Capital
Merck Global Health Innovation Fund, LLC
Merck Ventures
Merieux Developpement
M12 (Microsoft Corporation)
Mitsubishi UFJ Capital
Motorola Solutions Venture Capital
MP Healthcare Venture Management
Nike Innovation + Fuel Lab
Novartis Venture Funds (Switzerland)
Novo Ventures
NTT DoCoMo Capital
NVIDIA GPU Ventures
Olympus
Pfizer Venture Investments
Proctor and Gamble Ventures
Qualcomm Ventures
Quintiles Transnational Corp (NovaQuest Capital Management)
Rakuten Ventures (Japan)
Robert Bosch Venture Capital
Roche Venture Fund
S.R. One, Limited (GSK)
SAIC Capital
Salesforce
Samsung Venture Investment
Sanofi Genzyme BioVentures
Sapphire Ventures
Shell Technology Ventures
Sony Innovation Fund
Swisscom Ventures (Cloud Innovation Lab)
Synchrony Financial
Takeda Research investment
Tate & Lyle Ventures
Telstra Ventures (Australia)
Tengelmann Ventures
Third Point Ventures
Toyota AI Ventures
T-Venture Holding
Unilever Technology Ventures
UPS Strategic Enterprise Fund
Verizon Ventures
Volvo Venture Capital
ZX Ventures (AB Inbev Venture Group) (backed by Anheuser-Busch InBev)